Alder BioPharmaceuticals’ IPO priced at $10 per share

Post navigation

← This firm has a Modumetal idea for the aerospace industry $31M gift will fund early stage UW research by high-tech entrepreneurs →

Comments are closed.

Home
Contact

About Us

Grants

Startup Investments
- Investing in Washington
- Active Portfolio & Exits
In Memoriam: David Galas, Ph.D. (1944-2023)

News
- Articles
- Videos
- Stories

LinkedIn
Twitter

Washington Research Foundation values diversity. We’re committed to diversity, equity and inclusion in our staff, our board of directors, and the researchers, entrepreneurs and organizations we fund. We encourage people of color, women and other underserved communities to apply for our employment, grant-making and investment opportunities.

Terms of Use
Privacy Policy
(206) 336-5600
Site by The Medium

About Us
Grants
Startup Investments
- Investing in Washington
- Active Portfolio & Exits
Stories
News
- Articles
- Videos
- Reports
Contact